Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Identification of potential CSF biomarkers in ALS
G. M. Pasinetti
, L. H. Ungar
,
D. J. Lange
, S. Yemul
, H. Deng
, X. Yuan
, R. H. Brown
, M. E. Cudkowicz
, K. Newhall
, E. Peskind
, S. Marcus
,
L. Ho
Brain-Body Center
Friedman Brain Institute
Graduate School of Biomedical Sciences
Icahn School of Medicine at Mount Sinai
Neurology
Psychiatry
Genetics and Genomic Sciences
Mount Sinai Center for Transformative Disease Modeling
Research output
:
Contribution to journal
›
Article
›
peer-review
200
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Identification of potential CSF biomarkers in ALS'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
CSF Biomarkers
100%
Potential Identification
100%
Protein Species
100%
Healthy Controls
40%
Peripheral Neuropathy
40%
Control Subjects
20%
Neurologic Disorders
20%
Specificity Protein 1
20%
Diagnostic Criteria
20%
Clinical Diagnosis
20%
Clinical Features
20%
Validation Studies
20%
Receiver Operating Characteristic Curve
20%
Disease Control
20%
Peptide Sequencing
20%
Mass Spectrometry
20%
Protein Biomarkers
20%
Current Diagnostics
20%
Biomarker Model
20%
Protein Modeling
20%
Cystatin C (Cys C)
20%
Protein Profile
20%
Proteomics Methods
20%
Protein Sequence Analysis
20%
Objective Biomarker
20%
CSF Protein
20%
ALS Disease
20%
Biomarker Patterns
20%
Neurosecretory Protein
20%
ALS Biomarkers
20%
Mass Spectrometry-based Proteomics
20%
Proteomics Discovery
20%
Surface-enhanced Laser Desorption/ionization Time-of-flight Mass Spectrometry
20%
Biochemistry, Genetics and Molecular Biology
Protein Sequencing
100%
Proteomics
100%
Mass Spectrometry
50%
Protein Cerebrospinal Fluid Level
50%
Cystatin C
50%
Surface-Enhanced Laser Desorption/Ionization
50%
Time-of-Flight Mass Spectrometry
50%
Neuroscience
Amyotrophic Lateral Sclerosis
100%
Biological Marker
100%
Protein Sequencing
18%
Mass Spectrometry
18%
Proteomics
18%
Neuropathy
18%
Cystatin
9%